glp-1 review Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Frontiers | GLP-1/GIP dual agonist
Description
Optimization of Tolerability and Efficacy of Dual Amylin and Calcitonin Receptor Agonist, KBP-089, through Dose Escalation and Combination with a GLP-1 Analogue
TBR News Media
And studies have found that many people who take them for diabetes or weight loss experience surprising side effects
[DOI] [PubMed] [Google Scholar] 233.Buse JB, Vilsboll T, Thurman J, et al
(2024) 10:e136
American College of Gastroenterology
